These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2858930)

  • 1. Fetal liver transplantation in the dog. I. Restoration of hemopoiesis with cryopreserved fetal liver cells from DLA-identical siblings.
    Prümmer O; Raghavachar A; Werner C; Calvo W; Carbonell F; Steinbach I; Fliedner TM
    Transplantation; 1985 Apr; 39(4):349-55. PubMed ID: 2858930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemopoiesis and immune functions in dogs following fetal liver transplantation.
    Prümmer O; Calvo W; Werner C; Carbonell F; Fliedner TM
    Prog Clin Biol Res; 1985; 193():175-94. PubMed ID: 3911210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fetal liver cell transplantation in dogs: results with DLA-compatible and incompatible grafts.
    Champlin R; Cain G; Stitzel KA; Gale RP
    Prog Clin Biol Res; 1985; 193():195-204. PubMed ID: 2868458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fetal liver transplantation in the dog. II. Repopulation of the granulocyte-macrophage progenitor cell compartment by fetal liver cells from DLA-identical siblings.
    Prümmer O; Werner C; Raghavachar A; Nothdurft W; Calvo W; Steinbach KH; Fliedner TM
    Transplantation; 1985 Nov; 40(5):498-503. PubMed ID: 2414868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 'Resistance' to unrelated, DLA-nonidentical canine marrow grafts is unrestricted by the major histocompatibility complex.
    Raff RF; Sandmaier BM; Graham T; Loughran TP; Pettinger M; Storb R
    Exp Hematol; 1994 Aug; 22(9):893-7. PubMed ID: 8062888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of recombinant canine stem cell factor, a c-kit ligand, on hematopoietic recovery after DLA-identical littermate marrow transplants in dogs.
    Schuening FG; von Kalle C; Kiem HP; Appelbaum FR; Deeg HJ; Pepe M; Gooley T; Graham TC; Hackman RC; Storb R
    Exp Hematol; 1997 Nov; 25(12):1240-5. PubMed ID: 9357967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engraftment of stem-cell-enriched bone marrow fractions in MHC-identical dogs after fractionated total-body irradiation.
    Walma EP; Vriesendorp HM; Zurcher C; van Bekkum DW
    Transplantation; 1987 Jun; 43(6):818-23. PubMed ID: 3296347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolerance in DLA-haploidentical canine littermates following CD6-depleted marrow transplantation and donor lymphocyte transfusion.
    Zorn J; Herber M; Schwamberger S; Panzer W; Adler H; Kolb HJ
    Exp Hematol; 2009 Aug; 37(8):998-1006. PubMed ID: 19446000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variation of treatment conditions alters the outcome of fetal liver transplantation in dogs.
    Prümmer O; Calvo W; Fliedner TM
    Thymus; 1987; 10(1-2):19-31. PubMed ID: 2963415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
    Strober S
    Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stem cells from peripheral blood and bone marrow: a comparative evaluation of the hemopoietic potential in the dog.
    Raghavachar A; Prümmer O; Fliedner TM; Calvo W; Steinbach IB
    Int J Cell Cloning; 1983 Sep; 1(4):191-205. PubMed ID: 6366082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved survival of lethally irradiated recipient mice transplanted with circulating progenitor cells mobilized by IL-8 after pretreatment with stem cell factor.
    Laterveer L; Zijlmans JM; Lindley IJ; Hamilton MS; Willemze R; Fibbe WE
    Exp Hematol; 1996 Oct; 24(12):1387-93. PubMed ID: 8913284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recipient-specific donor cytotoxic T lymphocytes enhance engraftment of unrelated, DLA non-identical canine marrow.
    Schwarzinger I; Raff RF; Flowers M; Niederwieser D; Graham T; Shulman H; Appelbaum FR; Schuening F; Storb R
    Bone Marrow Transplant; 1994 Mar; 13(3):303-9. PubMed ID: 8199572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of in vivo administration of IL-3 and IL-6, alone and in combination with G-CSF, GM-CSF or IL-1, on haematopoiesis, graft-versus-host disease and survival after murine haematopoietic stem cell transplantation.
    Atkinson K; Vos B; Kang-Er Z; Guiffre A; Seymour R; Gillis S
    Cytokines Mol Ther; 1995 Mar; 1(1):47-55. PubMed ID: 9384663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between bone marrow and G-CSF-mobilized peripheral blood allografts undergoing clinical scale CD34+ cell selection.
    Hassan HT; Zeller W; Stockschläder M; Krüger W; Hoffknecht MM; Zander AR
    Stem Cells; 1996 Jul; 14(4):419-29. PubMed ID: 8843543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transplantation of DLA-compatible and incompatible fetal liver hematopoietic cells in dogs.
    Cain G; Stitzel K; Gale R; Champlin R
    Transplantation; 1987 Dec; 44(6):742-7. PubMed ID: 2892290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recovery of CFU-GM from cryopreserved marrow and in vivo evaluation after autologous bone marrow transplantation are predictive of engraftment.
    Douay L; Gorin NC; Mary JY; Lemarie E; Lopez M; Najman A; Stachowiak J; Giarratana MC; Baillou C; Salmon C
    Exp Hematol; 1986 Jun; 14(5):358-65. PubMed ID: 3519263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid engraftment after allogeneic transplantation of density-enriched peripheral blood CD34+ cells in patients with advanced hematologic malignancies.
    Cao TM; Kusnierz-Glaz C; Valone F; Stockerl-Goldstein KE; Hu WW; Johnston L; Blume KG; Strober S; Negrin RS
    Cancer; 2001 Jun; 91(12):2205-13. PubMed ID: 11413507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients.
    Lazarus HM; Koc ON; Devine SM; Curtin P; Maziarz RT; Holland HK; Shpall EJ; McCarthy P; Atkinson K; Cooper BW; Gerson SL; Laughlin MJ; Loberiza FR; Moseley AB; Bacigalupo A
    Biol Blood Marrow Transplant; 2005 May; 11(5):389-98. PubMed ID: 15846293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.